Fingerprint
Dive into the research topics of 'Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically